Kidney problems

Kidney problems features

• 

  HIV and TB in Practice for nurses: non-communicable diseases, HIV and TB

  Conditions such as cancer, heart disease and diabetes in low- and middle-income countries, and awareness of these conditions in people living with HIV and/or TB. ...

  From:  HIV & AIDS treatment in practice

• 

  Managing kidney disease in people living with HIV

  Part of a series on kidney disease in resource-limited settings. This edition looks at assessment and management of kidney disease in people with HIV....

  From:  HIV & AIDS treatment in practice

• 

  Acute and chronic kidney disease

  Part of a series on kidney disease in resource-limited settings. This edition looks at the causes and prevalence of acute and chronic kidney disease in...

  From:  HIV & AIDS treatment in practice

• 

  Kidney disease in people with HIV: a clinical review (part one)

  First in a series on kidney disease in resource-limited settings. This edition covers the scale of the problem, diagnosing kidney disease and monitoring kidney function....

  From:  HIV & AIDS treatment in practice

• 

  HIV and the kidneys

  It’s becoming increasingly clear that, when it comes to HIV, amongst the most vulnerable organs in the body are those two little waste filters in the small...

  From:  HIV treatment update

Kidney problems news from aidsmap

• New pro-drug tenofovir alafenamide appears equally effective but better tolerated

  Tenofovir alafenamide fumarate or TAF (formerly GS-7340), a new pro-drug of the widely used NRTI tenofovir, reaches cells harbouring HIV more easily than the older tenofovir disoproxil fumarate (TDF), allowing for similar antiviral efficacy with smaller doses and with ...

  07 March 2013 | Liz Highleyman

• Tenofovir, atazanavir/ritonavir and Kaletra associated with kidney problems in patients taking HIV therapy

  Data from a large study into the safety of anti-HIV drugs suggest that the antiretrovirals tenofovir (Viread, also in Truvada, Atripla and Eviplera), atazanavir (Reyataz) and lopinavir/ritonavir (Kaletra) each have an independent association with a decline in kidney function. ...

  15 February 2013 | Michael Carter

• Obesity is a risk factor for co-occuring chronic health problems in patients with HIV

  Obesity is associated with the clustering of multiple health problems in HIV-positive people, investigators from the US report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. Compared to people of a healthy weight, obese individuals were ...

  10 October 2012 | Michael Carter

• Starting HIV treatment reduces the risk of serious non-AIDS-related diseases

  Serious non-AIDS-defining illnesses are common in people recently diagnosed with HIV, Spanish investigators report in the online edition of AIDS. “Clinicians should be aware that during the initial follow-up after HIV diagnosis NAE [non-AIDS events] do occur,” comment the authors. ...

  09 October 2012 | Michael Carter

• Integrated analysis shows 'Quad' pill has potent activity with fewer side-effects

  An integrated analysis of data from phase II and III trials showed that the 'Quad' single-tablet regimen has antiviral efficacy at least as good as comparison regimens and is associated with fewer adverse events than Atripla or ritonavir-boosted atazanavir (Reyataz), researchers ...

  12 September 2012 | Liz Highleyman

• Chronic hepatitis C virus infection increases risk of death from both liver disease and non-liver-related causes

  As well as increasing the risk of death from liver disease, chronic hepatitis C virus infection increased the risk of death from circulatory and kidney disease as well as several non-liver-related cancers, investigators report in the August 15th edition ...

  05 September 2012 | Michael Carter

• Atazanavir/ritonavir more likely to cause kidney stones than other ritonavir-boosted protease inhibitors

  Treatment with ritonavir-boosted atazanavir is associated with a much higher risk of kidney stones compared to other ritonavir-boosted protease inhibitors, Japanese investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. There was also a high ...

  29 August 2012 | Michael Carter

• Starting HIV treatment reduces risk of kidney disease

  Starting HIV treatment reduces the risk of chronic kidney disease, US investigators report in the online edition of AIDS. This was especially the case for patients who experienced robust increases in their CD4 cell count and falls in their ...

  23 August 2012 | Michael Carter

• Chronic hepatitis C infection more than doubles the risk of kidney disease for people with HIV

  A detectable hepatitis C viral load is associated with an increased risk of chronic kidney disease for people with HIV, European investigators report in the online edition of AIDS. Patients with ongoing hepatitis C replication were significantly more likely ...

  18 July 2012 | Michael Carter

• Diabetes increases risk of chronic kidney disease for people with HIV: effect greater than for either disease alone

  Diabetes increases the risk of the progression of chronic kidney disease for patients with HIV, US investigators report in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The association was significant even after controlling for traditional ...

  24 May 2012 | Michael Carter

More news

Kidney problems news selected from other sources

• Tenofovir May Raise Risk of Kidney Damage, but Effect Tapers Over Time

  Tenofovir raises the risk of kidney dysfunction among people with HIV, but the adverse effect occurs mostly within the first two years of therapy.  

  14 February 2013 | AIDSMeds

• Kidney disease in HIV-Infected Patients: Guideline and Commentary

  The New York State Department of Health AIDS Institute has issued timely new guidelines on kidney disease in HIV-infected adults. Key points emphasize the importance of informing and educating HIV-infected patients about the increased risk for kidney disease; routinely assessing kidney function in HIV-infected patients; recommending earlier antiretroviral therapy (ART) initiation to patients with HIV-associated nephropathy; and assessing ART medication dosages, as well as other medications, when a patient's GFR reaches ≤ 50 mL/min.

  17 October 2012 | Medscape (requires registration)

• More HIV-Positive Patients Receive Organ Transplants

  Hospitals are increasingly willing to transplant vital and scarce organs into people who have HIV, a once-unthinkable step now made possible with drug regimens that are helping such patients live longer.

  12 October 2012 | Wall Street Journal

• Plea to end transplant ban between HIV patients

  A federal ban that forbids HIV-positive donors from giving organs to HIV-positive recipients is outdated and unnecessarily restrictive and should be repealed for the benefit of all transplant patients, says a growing clutch of health care and public health experts.

  02 July 2012 | San Francisco Chronicle

• AIDS down, heart disease up in hospital admissions of HIV+ in US

  Hospital admissions for AIDS illnesses dropped steadily from 2001 to 2008 in a four-center US study, while admissions for cardiovascular disease in HIV-positive people rose.

  29 March 2012 | International AIDS Society

• Kidneys Take Centre Stage

  Maggie Atkinson shines a much-needed spotlight on the latest research on HIV and kidney health and updates us on her efforts to keep her pair of these unassuming stars performing smoothly.

  06 February 2012 | The Positive Side

• 2 HIV patients undergo kidney transplant in Bangalore hospital

  Two HIV positive patients from East Africa, who were suffering from renal problems, have got a new lease of life after kidney transplantation surgeries at a private hospital here.

  22 December 2011 | IBN Live

• No HIV Disease Progression in Transplant Recipients

  Now that people infected with HIV are living longer, physicians are seeing a growing number who need kidney or liver transplants because of comorbid conditions. But what happens when you take patients in an immunosuppressed population, give them new organs, and further immunosuppress them with drugs to prevent rejection of those organs?

  19 November 2011 | Medscape (requires free registration)

• AMA Supports Allowing Research on Organ Transplantation Between HIV-Infected Individuals

  The American Medical Association (AMA) today voted to support amending a federal law that bars clinical research of HIV-infected organ donation, as a potentially lifesaving measure for people living with HIV.

  15 November 2011 | American Medical Association

• 2011 European AIDS Clinical Society adult treatment guidelines

  Updated adult treatment guidelines were issued by the European AIDS Clinical Society at the 12th European AIDS Conference, Belgrade, 12-15 October 2011. The guidelines include specific recommendations on managing co-morbidities and hepatitis B coinfection in people living with HIV.

  17 October 2011 | EACS

More news